513 related articles for article (PubMed ID: 22365245)
1. Idiopathic pulmonary fibrosis: phenotypes and comorbidities.
Fell CD
Clin Chest Med; 2012 Mar; 33(1):51-7. PubMed ID: 22365245
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.
Buendía-Roldán I; Mejía M; Navarro C; Selman M
Respir Med; 2017 Aug; 129():46-52. PubMed ID: 28732835
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities.
King CS; Nathan SD
Lancet Respir Med; 2017 Jan; 5(1):72-84. PubMed ID: 27599614
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
Suzuki A; Kondoh Y
Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
[TBL] [Abstract][Full Text] [Related]
5. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
Sato S; Koike T; Hashimoto T; Ishikawa H; Okada A; Watanabe T; Tsuchida M
Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):216-23. PubMed ID: 27052999
[TBL] [Abstract][Full Text] [Related]
6. IPF, comorbidities and management implications.
Vancheri C; Cottin V; Kreuter M; Hilberg O
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():17-23. PubMed ID: 26237439
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
Ryerson CJ; Hartman T; Elicker BM; Ley B; Lee JS; Abbritti M; Jones KD; King TE; Ryu J; Collard HR
Chest; 2013 Jul; 144(1):234-240. PubMed ID: 23370641
[TBL] [Abstract][Full Text] [Related]
8. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema.
Jacob J; Bartholmai BJ; Rajagopalan S; Karwoski R; Nair A; Walsh SLF; Barnett J; Cross G; Judge EP; Kokosi M; Renzoni E; Maher TM; Wells AU
Respirology; 2018 Jun; 23(6):593-599. PubMed ID: 29237236
[TBL] [Abstract][Full Text] [Related]
9. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.
García-Sancho C; Buendía-Roldán I; Fernández-Plata MR; Navarro C; Pérez-Padilla R; Vargas MH; Loyd JE; Selman M
Respir Med; 2011 Dec; 105(12):1902-7. PubMed ID: 21917441
[TBL] [Abstract][Full Text] [Related]
10. How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard C; Hilberg O; Bendstrup E
Respir Med; 2014 Apr; 108(4):647-53. PubMed ID: 24529739
[TBL] [Abstract][Full Text] [Related]
11. The impact of emphysema in pulmonary fibrosis.
Cottin V
Eur Respir Rev; 2013 Jun; 22(128):153-7. PubMed ID: 23728869
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
Raghu G; Amatto VC; Behr J; Stowasser S
Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities of IPF: How do they impact on prognosis.
Torrisi SE; Vancheri A; Pavone M; Sambataro G; Palmucci S; Vancheri C
Pulm Pharmacol Ther; 2018 Dec; 53():6-11. PubMed ID: 30193867
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension.
Mejía M; Carrillo G; Rojas-Serrano J; Estrada A; Suárez T; Alonso D; Barrientos E; Gaxiola M; Navarro C; Selman M
Chest; 2009 Jul; 136(1):10-15. PubMed ID: 19225068
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
Alfaro TM; Robalo Cordeiro C
Ther Adv Respir Dis; 2020; 14():1753466620910092. PubMed ID: 32167024
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic pulmonary fibrosis: evolving concepts.
Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis: the turning point is now!
Funke M; Geiser T
Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic pulmonary fibrosis: diagnosis and prognostic evaluation.
Poletti V; Ravaglia C; Buccioli M; Tantalocco P; Piciucchi S; Dubini A; Carloni A; Chilosi M; Tomassetti S
Respiration; 2013; 86(1):5-12. PubMed ID: 23816667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
